NextPharma Email Format
Pharmaceutical ManufacturingEngland, United Kingdom501-1000 Employees
NextPharma is a European contract development and manufacturing organization (CDMO) in the pharmaceutical, nutraceutical, biotech and healthcare industries, based in London, United Kingdom (SW1H 0HW). It provides development and manufacturing services with fast, flexible and personalized solutions for worldwide markets. The company develops and manufactures a broad range of dosage forms, including solids (tablets, hard and soft capsules, powders), non-sterile liquids, sterile liquids and semi-solids, with specialized containment areas for hormones, narcotics, beta-lactam antibiotics, highly potent compounds and clinical trials services. NextPharma operates centers of excellence across Europe and the UK, with sites in Germany (Berlin, Bielefeld, Goettingen, Waltrop), France (Limay, Ploermel), Finland (Tampere), the UK (Edinburgh) and Norway (Asker). The organization employs 501 to 1,000 people and has expanded its footprint through acquisitions and facility investments in Europe and the United States, including facilities related to Tampere, Edinburgh and Ploermel, as well as asset acquisitions from Lonza in 2021.